Biocardia Inc (BCDA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $12.58M
Last updated: Nov 17, 2026 at 11:04 AM ET
Biocardia Inc (BCDA) Competitors
The companies most similar to Biocardia are Dare Bioscience (DARE), Cyclerion Therapeutics (CYCN) and Biovie (BIVI). By market cap, Biocardia ranks 8th of the 13 companies on this page; CervoMed (CRVO) is the largest at $25.57M.
Peer Comparison
BCDA's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Biocardia (BCDA) | $12.58M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Dare Bioscience Inc (DARE) | $12.93M | N/A | 6.4x | 0.0% | N/A | 499.6% | 0.00% |
| Cyclerion Therapeutics Inc (CYCN) | $15.73M | N/A | N/A | 0.0% | N/A | -43.2% | 0.00% |
| Biovie Inc (BIVI) | $12.12M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Passage Bio Inc (PASG) | $13.68M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CytoMed Therapeutics Limited Ordinary Shares (GDTC) | $9.90M | N/A | 16.4x | 0.0% | -72.3% | -15.9% | 0.00% |
| Cardio Diagnostics Holdings Inc (CDIO) | $5.59M | N/A | 348.9x | 0.0% | N/A | 25.7% | 0.00% |
| CervoMed Inc. (CRVO) | $25.57M | N/A | N/A | 0.0% | N/A | -99.6% | 0.00% |
| Citius Pharmaceuticals Inc (CTXR) | $14.69M | N/A | 1.9x | 0.0% | -84.3% | 0.0% | 0.00% |
| FibroBiologics, Inc. Common Stock (FBLG) | $6.57M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $5.39M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Celularity Inc (CELU) | $20.45M | N/A | 1.0x | -245.7% | N/A | -5.3% | 0.00% |
| Collplant Biotechnologies Ltd (CLGN) | $14.27M | N/A | 21.0x | 0.0% | N/A | -39.7% | 0.00% |
| Peer median | $13.30M | N/A | 11.4x | 0.0% | -78.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Biocardia, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Dare Bioscience Inc (DARE) | Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. | DARE competitors |
| Cyclerion Therapeutics Inc (CYCN) | Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development... | |
| Biovie Inc (BIVI) | BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States. | BIVI competitors |
| Passage Bio Inc (PASG) | Passage Bio, Inc., a genetic drug company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases. | PASG competitors |
| CytoMed Therapeutics Limited Ordinary Shares (GDTC) | CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human... | |
| Cardio Diagnostics Holdings Inc (CDIO) | Cardio Diagnostics Holdings Inc (CDIO) is a pioneering biotechnology firm focused on enhancing cardiovascular health through innovative diagnostic solutions. | CDIO competitors |
| CervoMed Inc. (CRVO) | CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. | CRVO competitors |
| Citius Pharmaceuticals Inc (CTXR) | Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. | CTXR competitors |
| FibroBiologics, Inc. Common Stock (FBLG) | FibroBiologics, Inc. is an innovative biotechnology company dedicated to advancing regenerative medicine through its proprietary fibroblast cell technology... | FBLG competitors |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | Cadrenal Therapeutics, Inc. (CVKD) is a clinical-stage biopharmaceutical firm dedicated to developing groundbreaking therapies for renal diseases and associated... | CVKD competitors |
| Celularity Inc (CELU) | Celularity Inc. is a pioneering biotechnology company focused on regenerative medicine through its innovative cellular products derived from the placenta. | CELU competitors |
| Collplant Biotechnologies Ltd (CLGN) | CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs... | CLGN competitors |
Frequently Asked Questions About BCDA
Who are Biocardia's main competitors?
The companies most similar to Biocardia include Dare Bioscience (DARE), Cyclerion Therapeutics (CYCN), Biovie (BIVI), Passage Bio (PASG) and CytoMed Therapeutics Limited Ordinary Shares (GDTC), listed from the closest match.
Who is Biocardia's biggest competitor?
CervoMed (CRVO) is the largest of the similar companies at $25.57M; Dare Bioscience (DARE) is the closest match by business profile, size, sector and industry.
How does BCDA stock compare with its competitors?
BCDA's net margin is 0.0% against a peer median of 0.0%.
Which of Biocardia's competitors pays a higher dividend?
Biocardia pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Biocardia bigger than its competitors?
No. Biocardia is 8th by market cap among the 13 companies on this page; the largest is CervoMed (CRVO) at $25.57M.
BCDA pages: Overview, Earnings, Forecast, Financials, Competitors